Article
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome
2025-04-22
Abstract excerpt
WHIM (Warts, Hypogammaglobulinemia, Infections and Myelokathexis) syndrome is an ultrarare inborn error of immunity caused by heterozygous, gain-of-function CXCR4 mutations that impede leukocyte egress from bone marrow, resulting in panleukopenia. The CXCR4 antagonist plerixafor (AMD3100, Mozobil) durably reverses panleukopenia and in most WHIM patients induces wart regression; however, its short half-life require...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 121a8da5-1116-5191-8825-e7e7dddcaecd
- DOI
- 10.1101/2025.04.19.25325865
